Abstract
Deficiency of alpha-1-antitrypsin (α1-AT, a major protease inhibitor controlling tissue degradation) is a genetic disorder transmitted in a codominant autosomal form. It has more than 100 genetically determined variants. This study attempted to determine the degree of association between serum α1-AT levels and phenotypes and to provide a strategy for reliable laboratory evaluation of deficiencies. The study group consisted of a 38-year-old male proband with clinical features of emphysema, his first-degree relatives, and healthy controls. Family history revealed a four-generation pedigree. Genomic DNA was isolated from peripheral blood leukocytes. Alpha-1-AT levels were determined from human serum by immunonephelometry. Phenotypes were determined by isoelectric focusing of blood samples. DNA sequences of coding exons were analyzed by the amplification DNA technique and direct sequencing. Inheritance and plasma levels of the ZZ, MM, M3S, and MZ phenotypes were confirmed by the family study. In the family members with deficiencies, plasma concentrations were 22.55% ± 5.15 (ZZ), 84.18% ± 5.18 (M3S), and 61.06% ± 7.15 (MZ) of the normal MM level. We found a close association between α1-AT level and genotype. A combination of genotyping, quantification, and phenotyping is the optimal strategy for the laboratory evaluation of α1-AT deficiency.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brantly M, Nukiwa T, Crystal RG (1988) Molecular basis of alpha-1-antitrypsin deficiency. Am J Med 84(6):13–31
Cox DW (2001) α1-AT deficiency. In: Scriver CR, Deaudet AL, Sly WS, Walle D (eds) Metabolic and molecular bases of inherited disease, Chap 219, 8th edn. McGraw-Hill, London, pp 5559–5584
Crowther DC, Belorgey D, Miranda E, Kinghorn KJ, Sharp LK, Lomas DA (2004) Practical genetics: alpha-1-antitrypsin deficiency and the serpinopathies. Eur J Hum Genet 12(3):167–172
DeMeo DL, Silverman EK (2004) Alpha 1-antitrypsin deficiency, 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk. Thorax 59(3):259–264
Fabbretti G, Sergi C, Consales G, Faa G, Brisigotti M, Romeo G, Callea F (1992) Genetic variants of alpha-1-antitrypsin (AAT). Liver 12:296–301
Gupta J, Bhadoria DP, Lal MK, Kukreti R, Chattopadhaya D, Gupta VK, Dabur R, Yadav V, Chhillar AK, Sharma GL (2005) Association of the PIM3 allele of the alpha-1-antitrypsin gene with chronic obstructive pulmonary disease. Clin Biochem 38(5):489–491
Kowalska A, Danker-Hopfe H, Wender M, Florczak J, Walter H (1996) Association between the PI*M3 allele of alpha-1-antitrypsin and Alzheimer’s disease? A preliminary report. Hum Genet 98(6):744–746
Kueppers F, Black LF (1974) Alpha 1-antitrypsin and its deficiency. Am Rev Respir Dis 110(2):176–194
Lodewyckx L, Vandevyver C, Vandervorst C, Van Steenbergen W, Raus J, Michiels L (2001) Mutation Detection in the alpha-1-antitrypsin gene (PI) using denaturing gradient gel electrophoresis. Hum Mutat 18(3):243–250
Long GL, Chandra T, Woo SL, Davie EW, Kurachi K (1984) Complete sequence of the cDNA for human a1-antitrypsin and the gene for the S variant. Biochemistry 23(21):4828–4837
Mahadeva R, Chang WS, Dafforn TR, Oakley DJ, Foreman RC, Calvin J, Wight DG, Lomas DA (1999) Heteropolymerization of S, I, and Z a1-antitrypsin and liver cirrhosis. J Clin Invest 103(7):999–1006
McCombe PA, Clark P, Frith JA, Hammond SR, Stewart GJ, Pollard JD, McLeod JG (1985) Alpha-1-antitrypsin phenotypes in demyelinating disease: an association between demyelinating disease and the allele PIM3. Ann Neurol 18(4):514–516
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215
Norman MR, Mowat AP, Hutchison DC (1997) Molecular basis, clinical consequences and diagnosis of α1-AT deficiency. Ann Clin Biochem 34:230–246
Nukiwa T, Satoh K, Brantly ML, Ogushi F, Fells GA, Courtney M, Crystal RG (1986) Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene. J Biol Chem 261(34):15989–15994.
Poller W, Meisen C, Olek K (1990) DNA polymorphisms of alpha 1-antitrypsin gene region in patients with chronic obstructive pulmonary disease. Eur J Clin Invest 20(1):1–7
Stein PE, Carrell RW (1995) What do dysfunctional serpins tell about molecular mobility and disease? Nat Struct Biol 2(2):96–113
Snyder MR, Katzmann JA, Butz ML, Wiley C, Yang P, Dawson DB, Halling KC, Highsmith WE, Thibodeau SN (2006) Diagnosis of alpha-1-antitrypsin deficiency: an algorithm of quantification, genotyping, and phenotyping. Clin Chem 52(12):2236–2242
Whitehouse DB, Lovegrove JU, Hopkinson DA (1989) Variation in alpha-1-antitrypsin phenotypes associated with penicillamine therapy. Clin Chim Acta 179(1):109–115
Whitehouse DB, Lovegrove JU, Mieli-Vergani G, Mowat AP, Hopkinson DA (1994) Variation in alpha-1-antitrypsin phenotypes associated with penicillamine therapy. Ann Hum Genet 58(1):11–17
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Calapoğlu, M., Değer, O., Balaban, F. et al. Analysis of the Alpha-1-Antitrypsin Deficient Alleles M3S, MZ, and ZZ by Biochemical and Molecular Methods: A Family Study. Biochem Genet 47, 33–41 (2009). https://doi.org/10.1007/s10528-008-9204-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10528-008-9204-4